PL
TYRA icon

Parkwood LLC’s Tyra Biosciences TYRA Stock Holding History

Parkwood LLC’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,056
Closed -$225K – 131
2024
Q2 		$225K Buy
+14,056
New +$242K 0.03% 116
2023
Q4 		– Sell
-16,967
Closed -$234K – 163
2023
Q3 		$234K Buy
+16,967
New +$252K 0.03% 124

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Parkwood LLC's TYRA Position: Q3 2024 in Review

Parkwood LLC sold out of Tyra Biosciences (TYRA) in Q3 2024, closing a stake of 14,056 shares — an estimated $225K sold.

Parkwood LLC first reported a position in TYRA in Q3 2023 and held it in 2 quarters. The position peaked at $234K in Q3 2023. 95 funds tracked by Wall St. Rank hold TYRA as of Q3 2024.

  • Parkwood LLC reported no remaining Tyra Biosciences position as of Q3 2024 after selling out during the quarter.
  • Parkwood LLC sold 14,056 Tyra Biosciences shares in Q3 2024, an estimated $225K.
  • Parkwood LLC first reported a position in Tyra Biosciences in Q3 2023 and held it in 2 quarters.
  • Parkwood LLC's Tyra Biosciences position peaked at $234K in Q3 2023.
  • 95 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2024.

Based on Parkwood LLC's 13F filing for Q3 2024, filed 14 Nov 2024.